You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 278 No. 11, September 17, 1997 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorials
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Preventing the Emergence of Antimicrobial Resistance

A Call for Action by Clinicians, Public Health Officials, and Patients

Benjamin Schwartz, MD; David M. Bell, MD; James M. Hughes, MD

JAMA. 1997;278(11):944-945.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The emerging global problem of antimicrobial resistance has multiple aspects and involves multiple pathogens. One common theme is that antimicrobial drug use exerts selective pressure favoring the emergence of resistance. Strategies to prevent the development and spread of antimicrobial resistance depend on the pathogens. For bacterial respiratory tract pathogens (eg, Streptococcus pneumoniae), controlling outpatient antimicrobial use is crucial1-3; for some enteric pathogens (eg, Salmonella), limiting antimicrobial use in animals is important4,5; and, for pathogens that cause nosocomial infections, improving inpatient antimicrobial use and infection control practices is necessary.6 Addressing antimicrobial use and resistance is one of the most urgent priorities in confronting emerging infectious disease threats.7,8

See also p 901.

Respiratory infections account for more than three quarters of the antimicrobial drug prescriptions written annually in physicians' offices.9 In this issue of JAMA, Gonzales et al10 identify antibiotic prescribing for adults with colds, nonspecific . . . [Full Text PDF of this Article]


Author Affiliations

From the National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Ga.


Footnotes

Reprints: James M. Hughes, MD, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop C-12, Atlanta, GA 30333.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.